Thomas Reynolds, CMO of Seattle Genetics to Speak at Antibody Conference June 7-8, 2012 in San Diego, CA
Thomas Reynolds, Chief Medical Officer at Seattle Genetics will give a featured presentation on “Empowering Antibodies Through Drug Conjugation – the Brentuximab Vedotin Story” at GTC’s Antibody Design and Discovery Conference (June 7-8, 2012 in San Diego, CA)
View full press release